Bukwang Pharm (003000) — Net Asset Quality Index
Bukwang Pharm (003000) has a Net Asset Quality Index of 72.1% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ₩472.99 Billion minus total liabilities of ₩132.16 Billion yields net assets of ₩340.83 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 003000 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Bukwang Pharm Net Asset Quality Index Over Time (2007–2024)
This chart shows how Bukwang Pharm's Net Asset Quality Index has evolved across 14 annual periods from 2007 to 2024. As of September 2025, the index stands at 72.1%, representing net assets of ₩340.83 Billion against total assets of ₩472.99 Billion KRW. For live market cap and overall valuation, see 003000 company net worth.
Annual Net Asset Quality Index for Bukwang Pharm (2007–2024)
The table below presents the year-by-year Net Asset Quality Index for Bukwang Pharm from 2007 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. Check 003000 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
| Year | Quality Index | Net Assets (KRW) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 65.4% | ₩244.15 Billion | ₩373.18 Billion | ₩129.03 Billion | ▲ +10.8 pp |
| 2023 | 54.6% | ₩234.26 Billion | ₩429.02 Billion | ₩194.75 Billion | ▼ -13.2 pp |
| 2022 | 67.8% | ₩271.85 Billion | ₩400.93 Billion | ₩129.08 Billion | ▼ -2.7 pp |
| 2021 | 70.5% | ₩280.06 Billion | ₩397.42 Billion | ₩117.36 Billion | ▲ +2.8 pp |
| 2020 | 67.6% | ₩271.19 Billion | ₩400.97 Billion | ₩129.78 Billion | ▼ -16.4 pp |
| 2019 | 84.0% | ₩326.49 Billion | ₩388.53 Billion | ₩62.05 Billion | ▲ +0.3 pp |
| 2018 | 83.8% | ₩413.44 Billion | ₩493.62 Billion | ₩80.17 Billion | ▼ -5.7 pp |
| 2017 | 89.4% | ₩211.30 Billion | ₩236.23 Billion | ₩24.93 Billion | ▼ -0.9 pp |
| 2016 | 90.3% | ₩214.63 Billion | ₩237.63 Billion | ₩23.00 Billion | ▲ +1.6 pp |
| 2015 | 88.8% | ₩225.15 Billion | ₩253.66 Billion | ₩28.51 Billion | ▲ +0.1 pp |
| 2014 | 88.7% | ₩210.00 Billion | ₩236.82 Billion | ₩26.82 Billion | ▲ +0.6 pp |
| 2013 | 88.1% | ₩201.07 Billion | ₩228.21 Billion | ₩27.14 Billion | ▲ +12.6 pp |
| 2008 | 75.5% | ₩174.01 Billion | ₩230.55 Billion | ₩56.54 Billion | ▼ -3.9 pp |
| 2007 | 79.4% | ₩170.63 Billion | ₩215.02 Billion | ₩44.39 Billion | — |